IL10 and glioblastoma: In particular, hypoxic and necrotic regions of GBM secrete chemokines such as interleukin-4 (IL-4) and interleukin-10 (IL-10), driving a shift from M1 (anti-tumor) to M2 (pro-tumor) TAMs.